STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
N
Not yet recruiting
- Myelodysplastic Syndromes
- decitabine and cedazuridine
- BMS-986253
- Bethesda, MarylandNational Institutes of Health Clinical Center
2022-04-07
Apr 7, 2022A
Completed
- Myelodysplastic Syndromes
- (no location specified)
2022-01-21
Jan 21, 2022C
Completed
- Leukemias
- Myelodysplastic Syndromes
- Houston, TexasThe University of Texas MD Anderson Cancer Center
2021-12-07
Dec 7, 2021T
No longer available
- Myelodysplastic Syndromes
- (no location specified)
2021-09-08
Sep 8, 2021R
Not yet recruiting
- Low Risk Myelodysplastic Syndromes
- R906289 Monosodium (R289 Na)
- (no location specified)
2022-03-25
Mar 25, 2022U
Active, not recruiting
- Myelodysplastic Syndromes
- Chronic Myelomonocytic Leukemia
- Rochester, New YorkUniversity of Rochester
2022-01-04
Jan 4, 2022W
Active, not recruiting
- Myelodysplastic Syndromes
- Saint Louis, MissouriWashington University School of Medicine
2022-03-23
Mar 23, 2022A
Recruiting
- MDS
- Myelodysplastic Syndromes
- APR-548 + Azacitidine
- Tampa, Florida
- +3 more
2022-01-18
Jan 18, 2022M
Withdrawn
- Myelodysplastic Syndromes
- Bronx, New YorkMontefiore Medical Center
2021-09-15
Sep 15, 2021Y
Withdrawn
- MDS
- New Haven, ConnecticutYale University; Smilow Cancer Center
2022-01-06
Jan 6, 2022M
Completed
- Myelodysplastic Syndromes
- selinexor (KPT-330)
- New York, New YorkMemorial Sloan Kettering Cancer Center
2022-02-11
Feb 11, 2022T
Withdrawn
- Myelodysplastic Syndromes (MDS)
- Pevonedistat
- +2 more
- (no location specified)
2021-09-23
Sep 23, 2021O
Active, not recruiting
- Lower-risk Myelodysplastic
- Tokyo, JapanNTT Medical Center Tokyo
2022-01-14
Jan 14, 2022M
Active, not recruiting
- Myelodysplastic Syndromes
- decitabine
- +6 more
- New York, New YorkMemorial Sloan Kettering Cancer Center
2021-05-07
May 7, 2021C
Completed
- Myelodysplastic Syndromes
- +2 more
- Azacitidine
- Ascorbic acid
- Cleveland, OhioCleveland Clinic, Case Comprehensive Cancer Center
2021-08-04
Aug 4, 2021A
Completed
- Myelodysplastic Syndromes
- Dresden, GermanyAcceleron Investigative Site
2021-04-29
Apr 29, 2021S
Not yet recruiting
- Myelodysplastic Syndromes
- +2 more
- (no location specified)
2021-11-29
Nov 29, 2021W
Terminated
- Previously Treated Myelodysplastic Syndromes
- 6,8-bis(benzylthio)octanoic acid
- Winston-Salem, North CarolinaComprehensive Cancer Center of Wake Forest University
2021-07-01
Jul 1, 2021G
Withdrawn
- Myelodysplastic Syndromes
- Acute Myeloid Leukemia
- Huixquilucan, Estado De México, MexicoGrupo Cooperativo de Hemopatías Malignas
2021-07-05
Jul 5, 2021S
Terminated
- Myelodysplastic Syndromes (MDS)
- Fort Myers, Florida
- +6 more
2021-11-18
Nov 18, 2021M
Active, not recruiting
- High Risk Myelodysplastic Syndrome
- Houston, TexasM D Anderson Cancer Center
2022-02-02
Feb 2, 2022C
Recruiting
- Refractory Acute Myeloid Leukemia
- +2 more
- Cleveland, OhioCleveland Clinic, Case Comprehensive Cancer Center
2022-03-15
Mar 15, 2022U
Recruiting
- High Grade Myelodysplastic Syndromes
- Aurora, ColoradoUniverstiy of Colorado Denver
2021-10-19
Oct 19, 2021A
Completed
- Myelodysplastic Syndrome (MDS)
- AMV564 14-Day CIV
- Duarte, California
- +4 more
2021-10-11
Oct 11, 2021T
Enrolling by invitation
- Myelodysplastic Syndromes
- Observation and necessary supportive care
- Suzhou, Jiangsu, ChinaThe First Affliated Hospital of Soochow University
2022-03-16
Mar 16, 2022